Lincoln Pharma Consolidated September 2018 Net Sales at Rs 102.60 crore, Up 14.44% Y-o-Y.
November 14, 2018 / 13:15 IST
| Reported Consolidated quarterly numbers for Lincoln Pharmaceuticals are: | | Net Sales at Rs 102.60 crore in September 2018 Up 14.44% from Rs. 89.65 crore in September 2017. | | Quarterly Net Profit at Rs. 15.00 crore in September 2018 Up 32.7% from Rs. 11.30 crore in September 2017. | | EBITDA stands at Rs. 23.52 crore in September 2018 Up 27.62% from Rs. 18.43 crore in September 2017. | | Lincoln Pharma EPS has Increased to Rs. 16.38 in September 2018 from Rs. 5.65 in September 2017. | | Lincoln Pharma shares closed at 267.35 on November 13, 2018 (NSE) and has given 21.19% returns over the last 6 months and 35.47% over the last 12 months. |
|
| Lincoln Pharmaceuticals | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'18 | Jun'18 | Sep'17 | | Net Sales/Income from operations | 102.60 | 99.82 | 89.65 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 102.60 | 99.82 | 89.65 | | EXPENDITURE | | Consumption of Raw Materials | 35.63 | 26.55 | 24.13 | | Purchase of Traded Goods | 13.39 | 10.91 | 15.05 | | Increase/Decrease in Stocks | 3.86 | 7.23 | 6.38 | | Power & Fuel | -- | -- | -- | | Employees Cost | 12.73 | 13.52 | 13.38 | | Depreciation | 1.51 | 1.58 | 1.81 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 17.90 | 18.32 | 15.28 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 17.58 | 21.71 | 13.62 | | Other Income | 4.43 | 2.30 | 2.99 | | P/L Before Int., Excpt. Items & Tax | 22.01 | 24.01 | 16.62 | | Interest | 1.75 | 1.33 | 1.50 | | P/L Before Exceptional Items & Tax | 20.26 | 22.68 | 15.12 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 20.26 | 22.68 | 15.12 | | Tax | 5.25 | 6.60 | 3.80 | | P/L After Tax from Ordinary Activities | 15.01 | 16.07 | 11.32 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 15.01 | 16.07 | 11.32 | | Minority Interest | -0.01 | -0.01 | -0.02 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 15.00 | 16.07 | 11.30 | | Equity Share Capital | 20.00 | 20.00 | 20.00 | | Reserves Excluding Revaluation Reserves | 199.54 | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 16.38 | 8.03 | 5.65 | | Diluted EPS | 16.38 | 8.03 | 5.65 | | EPS After Extra Ordinary | | Basic EPS | 16.38 | 8.03 | 5.65 | | Diluted EPS | 16.38 | 8.03 | 5.65 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
